Esentra 120mg Injection

About Esentra 120mg Injection

Esentra 120mg Injection (Denosumab)

Esentra 120mg Injection contains Denosumab as its active ingredient. It is primarily used to treat osteoporosis, a condition characterized by weakened bones. Additionally, it is prescribed to prevent bone complications in patients with multiple myeloma and bone metastases from certain cancers.

Denosumab works by inhibiting RANK ligand, a protein responsible for bone tissue breakdown. Clinical studies have shown that it significantly increases bone density and reduces the risk of fractures, particularly in postmenopausal women and patients experiencing cancer-related bone loss. Patients with moderate renal impairment may require close monitoring of their kidney function during treatment.

Precautions & Contraindications

• Allergic Reactions: Should not be used in individuals with known hypersensitivity to Denosumab or its components.
• Calcium & Vitamin D: Adequate supplementation is essential during treatment.
• Pediatric Use: Not approved for children and adolescents under 18 years, as its safety and effectiveness in this group have not been established.
• Hypoparathyroidism: Use with caution in individuals with low parathyroid hormone levels.

Consult your doctor before starting Esentra 120mg Injection to ensure safe and effective use.